Recent advances in microRNA-mediated gene regulation in chronic lymphocytic leukemia

Clinical Biochemistry

Volumn 46, Issue 10-11, 2013, Pages 901-908

  Srivastava, Swati ^a   Tsongalis, Gregory J ^a   Kaur, Prabhjot ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Chronic lymphocytic leukemia; CLL; MicroRNA; MiRNA

Indexed keywords

MICRORNA; MICRORNA 15A; MICRORNA 16; MICRORNA 181; MICRORNA 223; MICRORNA 29; MICRORNA 34A; PROTEIN P53; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

CHROMOSOME 13Q; CHROMOSOME 17P; CHRONIC LYMPHATIC LEUKEMIA; GENE CONTROL; GENE DELETION; GENE TARGETING; LYMPHOCYTE COUNT; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

ANIMALS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION, LEUKEMIC; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MICRORNAS; RNA, NEOPLASM;

EID: 84886085652     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.03.007     Document Type: Review

References (94)

1. WHO classification of tumors of hematopoietic and lymphoid tissues. Chronic lymphocytic leukemia/small lymphocytic lymphoma. 2008, 180-182. (Chapter 10). 4th ed.
2. Hallek M., Cheson B.D., Catovsky D., Caligaris-Cappio F., Dighiero G., Dohner H., et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008, 111:5446-5456.
3. SEER stat fact sheets: chronic lymphocytic leukemia http://seer.cancer.gov/statfacts/html/clyl.html.
4. Montserrat E. New prognostic markers in CLL. Hematology Am Soc Hematol Educ Program 2006, 279-284.
5. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
6. Bartel D.P., Chen C.Z. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 2004, 5:396-400.
7. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
8. Griffiths-Jones S., Saini H.K., van Dongen S., Enright A.J. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008, 36:D154-D158.
9. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
10. Lee R.C., Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001, 294:862-864.
11. Berezikov E., Chung W.J., Willis J., Cuppen E., Lai E.C. Mammalian mirtron genes. Mol Cell 2007, 28:328-336.
12. Okamura K., Hagen J.W., Duan H., Tyler D.M., Lai E.C. The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila. Cell 2007, 130:89-100.
13. Ruby J.G., Jan C.H., Bartel D.P. Intronic microRNA precursors that bypass Drosha processing. Nature 2007, 448:83-86.
14. Borchert G.M., Lanier W., Davidson B.L. RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol 2006, 13:1097-1101.
15. Lee Y., Kim M., Han J., Yeom K.H., Lee S., Baek S.H., et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004, 23:4051-4060.
16. Lee Y., Han J., Yeom K.H., Jin H., Kim V.N. Drosha in primary microRNA processing. Cold Spring Harb Symp Quant Biol 2006, 71:51-57.
17. Gregory R.I., Yan K.P., Amuthan G., Chendrimada T., Doratotaj B., Cooch N., et al. The microprocessor complex mediates the genesis of microRNAs. Nature 2004, 432:235-240.
18. Zeng Y., Yi R., Cullen B.R. Recognition and cleavage of primary microRNA precursors by the nuclear processing enzyme Drosha. EMBO J 2005, 24:138-148.
19. Lund E., Guttinger S., Calado A., Dahlberg J.E., Kutay U. Nuclear export of microRNA precursors. Science 2004, 303:95-98.
20. Lee Y., Jeon K., Lee J.T., Kim S., Kim V.N. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 2002, 21:4663-4670.
21. Pratt A.J., MacRae I.J. The RNA-induced silencing complex: a versatile gene-silencing machine. J Biol Chem 2009, 284:17897-17901.
22. Lau P.W., Potter C.S., Carragher B., MacRae I.J. Structure of the human Dicer-TRBP complex by electron microscopy. Structure 2009, 17:1326-1332.
23. Wang H.W., Noland C., Siridechadilok B., Taylor D.W., Ma E., Felderer K., et al. Structural insights into RNA processing by the human RISC-loading complex. Nat Struct Mol Biol 2009, 16:1148-1153.
24. Lau P.W., Guiley K.Z., De N., Potter C.S., Carragher B., MacRae I.J. The molecular architecture of human Dicer. Nat Struct Mol Biol 2012, 19:436-440.
25. Esquela-Kerscher A., Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006, 6:259-269.
26. Di Leva G., Briskin D., Croce C.M. MicroRNA in cancer: new hopes for antineoplastic chemotherapy. Ups J Med Sci 2012, 117:202-216.
27. Kozomara A., Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011, 39:D152-D157.
28. Griffiths-Jones S., Grocock R.J., van Dongen S., Bateman A., Enright A.J. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006, 34:D140-D144.
29. Griffiths-Jones S. The microRNA Registry. Nucleic Acids Res 2004, 32:D109-D111.
30. Wang Y., Chen X., Jiang W., Li L., Li W., Yang L., et al. Predicting human microRNA precursors based on an optimized feature subset generated by GA-SVM. Genomics 2011, 98:73-78.
31. Sethupathy P., Megraw M., Hatzigeorgiou A.G. A guide through present computational approaches for the identification of mammalian microRNA targets. Nat Methods 2006, 3:881-886.
32. Chen Y. An integrated cross-database search system for microRNA. BMEI '09. 2nd international conference on 2009, 1-4. (17-19).
33. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., et al. Frequent deletions and down-regulation of micro-RNA genes miR-15 and miR-16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002, 99:15524-15529.
34. Bullrich F., Fujii H., Calin G., Mabuchi H., Negrini M., Pekarsky Y., et al. Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene. Cancer Res 2001, 61:6640-6648.
35. Liu Y., Corcoran M., Rasool O., Ivanova G., Ibbotson R., Grander D., et al. Cloning of two candidate tumor suppressor genes within a 10kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia. Oncogene 1997, 15:2463-2473.
36. Lagos-Quintana M., Rauhut R., Lendeckel W., Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001, 294:853-858.
37. Migliazza A., Bosch F., Komatsu H., Cayanis E., Martinotti S., Toniato E., et al. Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia. Blood 2001, 97:2098-2104.
38. Pfeifer D., Pantic M., Skatulla I., Rawluk J., Kreutz C., Martens U.M., et al. Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays. Blood 2007, 109:1202-1210.
39. Calin G.A., Ferracin M., Cimmino A., Di Leva G., Shimizu M., Wojcik S.E., et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005, 353:1793-1801.
40. Raveche E.S., Salerno E., Scaglione B.J., Manohar V., Abbasi F., Lin Y.C., et al. Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. Blood 2007, 109:5079-5086.
41. Smonskey M.T., Block A.W., Deeb G., Chanan-Khan A.A., Bernstein Z.P., Miller K.C., et al. Monoallelic and biallelic deletions of 13q14.3 in chronic lymphocytic leukemia: FISH vs miRNA RT-qPCR detection. Am J Clin Pathol 2012, 137:641-646.
42. Cimmino A., Calin G.A., Fabbri M., Iorio M.V., Ferracin M., Shimizu M., et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 2005, 102:13944-13949.
43. Hanlon K., Rudin C.E., Harries L.W. Investigating the targets of MIR-15a and MIR-16-1 in patients with chronic lymphocytic leukemia (CLL). PLoS One 2009, 4:e7169.
44. Fulci V., Chiaretti S., Goldoni M., Azzalin G., Carucci N., Tavolaro S., et al. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 2007, 109:4944-4951.
45. Linsley P.S., Schelter J., Burchard J., Kibukawa M., Martin M.M., Bartz S.R., et al. Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol 2007, 27:2240-2252.
46. Klein U., Lia M., Crespo M., Siegel R., Shen Q., Mo T., et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 2010, 17:28-40.
47. Rawstron A.C., Bennett F.L., O'Connor S.J., Kwok M., Fenton J.A., Plummer M., et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 2008, 359:575-583.
48. Masood A., Chitta K., Paulus A., Khan A.N., Sher T., Ersing N., et al. Downregulation of BCL2 by AT-101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent manner. Br J Haematol 2012, 157(1):59-66.
49. Palamarchuk A., Efanov A., Nazaryan N., Santanam U., Alder H., Rassenti L., et al. 13q14 deletions in CLL involve cooperating tumor suppressors. Blood 2010, 115:3916-3922.
50. Pekarsky Y., Santanam U., Cimmino A., Palamarchuk A., Efanov A., Maximov V., et al. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 2006, 66:11590-11593.
51. Mott J.L., Kobayashi S., Bronk S.F., Gores G.J. miR-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 2007, 26:6133-6140.
52. Zhao J.J., Lin J., Lwin T., Yang H., Guo J., Kong W., et al. microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood 2010, 115:2630-2639.
53. Han Y.C., Park C.Y., Bhagat G., Zhang J., Wang Y., Fan J.B., et al. microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J Exp Med 2010, 207:475-489.
54. Virgilio L., Narducci M.G., Isobe M., Billips L.G., Cooper M.D., Croce C.M., et al. Identification of the TCL1 gene involved in T-cell malignancies. Proc Natl Acad Sci U S A 1994, 91:12530-12534.
55. Bichi R., Shinton S.A., Martin E.S., Koval A., Calin G.A., Cesari R., et al. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci U S A 2002, 99:6955-6960.
56. Herling M., Patel K.A., Khalili J., Schlette E., Kobayashi R., Medeiros L.J., et al. TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state. Leukemia 2006, 20:280-285.
57. Santanam U., Zanesi N., Efanov A., Costinean S., Palamarchuk A., Hagan J.P., et al. Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression. Proc Natl Acad Sci U S A 2010, 107:12210-12215.
58. Gladkikh A., Potashnikova D., Korneva E., Khudoleeva O., Vorobjev I. Cyclin D1 expression in B-cell lymphomas. Exp Hematol 2010, 38:1047-1057.
59. Gaudio E., Spizzo R., Paduano F., Luo Z., Efanov A., Palamarchuk A., et al. Tcl1 interacts with Atm and enhances NF-kappaB activation in hematologic malignancies. Blood 2012, 119:180-187.
60. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 2003, 3:155-168.
61. Narducci M.G., Virgilio L., Isobe M., Stoppacciaro A., Elli R., Fiorilli M., et al. TCL1 oncogene activation in preleukemic T cells from a case of ataxia-telangiectasia. Blood 1995, 86:2358-2364.
62. Thick J., Metcalfe J.A., Mak Y.F., Beatty D., Minegishi M., Dyer M.J., et al. Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients. Oncogene 1996, 12:379-386.
63. Visone R., Veronese A., Balatti V., Croce C.M. MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia. Oncotarget 2012, 3:195-202.
64. Calin G.A., Liu C.G., Sevignani C., Ferracin M., Felli N., Dumitru C.D., et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A 2004, 101:11755-11760.
65. Marton S., Garcia M.R., Robello C., Persson H., Trajtenberg F., Pritsch O., et al. Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis. Leukemia 2008, 22:330-338.
66. Stamatopoulos B., Meuleman N., Haibe-Kains B., Saussoy P., Van Den Neste E., Michaux L., et al. microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Blood 2009, 113:5237-5245.
67. Rossi S., Shimizu M., Barbarotto E., Nicoloso M.S., Dimitri F., Sampath D., et al. microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival. Blood 2010, 116:945-952.
68. Vousden K.H., Lane D.P. p53 in health and disease. Nat Rev Mol Cell Biol 2007, 8:275-283.
69. Grever M.R., Lucas D.M., Dewald G.W., Neuberg D.S., Reed J.C., Kitada S., et al. Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997. J Clin Oncol 2007, 25:799-804.
70. Zenz T., Mohr J., Eldering E., Kater A.P., Buhler A., Kienle D., et al. miR-34a as part of the resistance network in chronic lymphocytic leukemia. Blood 2009, 113:3801-3808.
71. Bommer G.T., Gerin I., Feng Y., Kaczorowski A.J., Kuick R., Love R.E., et al. p53-mediated activation of miR-NA34 candidate tumor-suppressor genes. Curr Biol 2007, 17:1298-1307.
72. Chang T.C., Wentzel E.A., Kent O.A., Ramachandran K., Mullendore M., Lee K.H., et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007, 26:745-752.
73. Corney D.C., Flesken-Nikitin A., Godwin A.K., Wang W., Nikitin A.Y. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 2007, 67:8433-8438.
74. He L., He X., Lim L.P., de Stanchina E., Xuan Z., Liang Y., et al. A microRNA component of the p53 tumour suppressor network. Nature 2007, 447:1130-1134.
75. Raver-Shapira N., Marciano E., Meiri E., Spector Y., Rosenfeld N., Moskovits N., et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007, 26:731-743.
76. Tarasov V., Jung P., Verdoodt B., Lodygin D., Epanchintsev A., Menssen A., et al. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 2007, 6:1586-1593.
77. Tazawa H., Tsuchiya N., Izumiya M., Nakagama H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci U S A 2007, 104:15472-15477.
78. Asslaber D., Pinon J.D., Seyfried I., Desch P., Stocher M., Tinhofer I., et al. microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia. Blood 2010, 115:4191-4197.
79. Fabbri M., Bottoni A., Shimizu M., Spizzo R., Nicoloso M.S., Rossi S., et al. Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA 2011, 305:59-67.
80. Danial N.N. BCL-2 family proteins: critical checkpoints of apoptotic cell death. Clin Cancer Res 2007, 13:7254-7263.
81. Aviram A., Rabizadeh E., Zimra Y., Yeshoron M., Marmelstein M., Shaklai M., et al. Expression of bcl-2 and bax in cells isolated from B-chronic lymphocytic leukemia patients at different stages of the disease. Eur J Haematol 2000, 64:80-84.
82. Buggins A.G., Pepper C.J. The role of Bcl-2 family proteins in chronic lymphocytic leukaemia. Leuk Res 2010, 34:837-842.
83. Goldin L.R., Slager S.L. Familial CLL: genes and environment. Hematology Am Soc Hematol Educ Program 2007, 339-345.
84. Wiley J.S., Dao-Ung L.P., Gu B.J., Sluyter R., Shemon A.N., Li C., et al. A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study. Lancet 2002, 359:1114-1119.
85. Bogunia-Kubik K., Mazur G., Urbanowicz I., Wrobel T., Kuliczkowski K., Wozniak M., et al. Lack of association between the TNF-alpha promoter gene polymorphism and susceptibility to B-cell chronic lymphocytic leukaemia. Int J Immunogenet 2006, 33:21-24.
86. Guzowski D., Chandrasekaran A., Gawel C., Palma J., Koenig J., Wang X.P., et al. Analysis of single nucleotide polymorphisms in the promoter region of interleukin-10 by denaturing high-performance liquid chromatography. J Biomol Tech 2005, 16:154-166.
87. Zhang Y., Lan Q., Rothman N., Zhu Y., Zahm S.H., Wang S.S., et al. A putative exonic splicing polymorphism in the BCL6 gene and the risk of non-Hodgkin lymphoma. J Natl Cancer Inst 2005, 97:1616-1618.
88. Nuckel H., Frey U.H., Bau M., Sellmann L., Stanelle J., Durig J., et al. Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia. Blood 2007, 109:290-297.
89. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
90. Li M., Li J., Ding X., He M., Cheng S.Y. microRNA and cancer. AAPS J 2010, 12:309-317.
91. Bartels C.L., Tsongalis G.J. MicroRNAs: novel biomarkers for human cancer. Clin Chem 2009, 55:623-631.
92. Ward B.P., Tsongalis G.J., Kaur P. MicroRNAs in chronic lymphocytic leukemia. Exp Mol Pathol 2011, 90:173-178.
93. Pritchard C.C., Cheng H.H., Tewari M. MicroRNA profiling: approaches and considerations. Nat Rev Genet 2012, 13:358-369.
94. Matolcsy A., Casali P., Warnke R.A., Knowles D.M. Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene. Blood 1996, 88:3937-3944.